The impact of clinical stage on prostate cancer survival following radical prostatectomy

Journal of Urology

Volumn 189, Issue 5, 2013, Pages 1707-1712

  Tollefson, Matthew K ^a   Karnes, R Jeffrey ^a   Rangel, Laureano J ^a   Bergstralh, Eric J ^a   Boorjian, Stephen A ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

disease progression; prostatectomy; prostatic neoplasms; risk factors

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; DISEASE SEVERITY; GLEASON SCORE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SALVAGE THERAPY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84876292492     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.065     Document Type: Article

References (29)

1. R. Siegel, D. Naishadham, A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10
2. B.M. Kuehn Institute of Medicine outlines priorities for comparative effectiveness research JAMA 302 2009 936
3. A. Sabolch, F.Y. Feng, S. Daignault-Newton Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation Int J Radiat Oncol Biol Phys 81 2011 e351
4. M. Spahn, S. Joniau, P. Gontero Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients Eur Urol 58 2010 1
5. A.W. Partin, J. Yoo, H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110
6. A.C. Reese, M.R. Cooperberg, P.R. Carroll Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease J Urol 184 2010 114
7. A.C. Reese, N. Sadetsky, P.R. Carroll Inaccuracies in assignment of clinical stage for localized prostate cancer Cancer 117 2011 283
8. American Joint Committee for Cancer Staging and End Results Reporting, American Cancer Society Manual for Staging of Cancer, 1977 1977 American Joint Committee for Cancer Staging and End Results Reporting Chicago 174
9. G.P. Swanson, M. Riggs, M. Hermans Pathologic findings at radical prostatectomy: risk factors for failure and death Urol Oncol 25 2007 110
10. C.R. Mitchell, S.A. Boorjian, E.C. Umbreit 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer BJU Int 110 2012 1709
11. A. Gallina, F.K. Chun, N. Suardi Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer BJU Int 101 2008 1513
12. F.M. Jhaveri, E.A. Klein, P.A. Kupelian Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration J Clin Oncol 17 1999 3167
13. M.R. Cooperberg, J.M. Broering, P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117
14. J.F. Ward, M.L. Blute, J. Slezak The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy J Urol 170 2003 1872
15. S.J. Freedland, E.B. Humphreys, L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433
16. C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591
17. S.A. Boorjian, R.H. Thompson, M.K. Tollefson Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence Eur Urol 59 2011 893
18. C.L. Amling, E.J. Bergstralh, M.L. Blute Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 165 2001 1146
19. S.A. Boorjian, R.J. Karnes, L.J. Rangel Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy J Urol 179 2008 1354
20. A.V. D'Amico, J. Moul, P.R. Carroll Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era J Clin Oncol 21 2003 2163
21. A.V. D'Amico, R. Whittington, S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
22. F.K. Chun, A. Briganti, T. Lebeau The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy Eur Urol 49 2006 273
23. C.G. Ramos, G.F. Carvalhal, D.S. Smith Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer J Urol 161 1999 1525
24. K.S. Choe, J.E. Cowan, J.M. Chan Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy J Clin Oncol 30 2012 3540
25. I. Thompson, J.B. Thrasher, G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106
26. C. Gosselaar, R. Kranse, M.J. Roobol The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer Prostate 68 2008 985
27. M.R. Cooperberg, D.J. Pasta, E.P. Elkin The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 173 2005 1938
28. S.F. Shariat, P.I. Karakiewicz, C.G. Roehrborn An updated catalog of prostate cancer predictive tools Cancer 113 2008 3075
29. A.J. Stephenson, P.T. Scardino, J.A. Eastham Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715